Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Amortization of Deferred Charges (2016 - 2020)

STRATA Skin Sciences (SSKN) has disclosed Amortization of Deferred Charges for 7 consecutive years, with -$79000.0 as the latest value for Q2 2020.

  • Quarterly Amortization of Deferred Charges fell 363.33% to -$79000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $254000.0 through Sep 2020, up 296.88% year-over-year, with the annual reading at $318000.0 for FY2019, N/A changed from the prior year.
  • Amortization of Deferred Charges hit -$79000.0 in Q2 2020 for STRATA Skin Sciences, down from $79000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $254000.0 in Q4 2019 to a low of -$79000.0 in Q2 2020.
  • Historically, Amortization of Deferred Charges has averaged $50428.6 across 4 years, with a median of $51000.0 in 2016.
  • Biggest YoY gain for Amortization of Deferred Charges was 192.59% in 2020; the steepest drop was 363.33% in 2020.
  • Year by year, Amortization of Deferred Charges stood at $55000.0 in 2016, then plummeted by 69.09% to $17000.0 in 2017, then skyrocketed by 1394.12% to $254000.0 in 2019, then crashed by 131.1% to -$79000.0 in 2020.
  • Business Quant data shows Amortization of Deferred Charges for SSKN at -$79000.0 in Q2 2020, $79000.0 in Q1 2020, and $254000.0 in Q4 2019.